In conclusion, our results show for the first time that colchicine given to patients admitted to the hospital with COVID-19-related symptoms may improve outcome and is associated with lower levels of inflammatory markers and faster normalization of these markers, including D-dimer, LDH, CRP, and ferritin. This evidence concerns the gene CRP and COVID-19.